The anti‐inflammatory effect of an oral immunoglobulin (IgA‐IgG) preparation and its possible relevance for the prevention of necrotizing enterocolitis

Acta Pædiatrica

Volumn 83, Issue , 1994, Pages 37-40

  Wolf, HM ^a   Eibl, MM ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Human monocytes; IgA IgG preparation; IL 6; TNF alpha

Indexed keywords

CD79B ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR;

CONFERENCE PAPER; DRUG EFFECT; HUMAN; MONOCYTE; NECROTIZING ENTERITIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; IMMUNOLOGY; INFANT; NEWBORN; PHYSIOLOGY; PSEUDOMEMBRANOUS COLITIS; REVIEW;

ADMINISTRATION, ORAL; CYTOKINES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; INTERLEUKIN-6; MONOCYTES; TUMOR NECROSIS FACTOR;

EID: 0028315367     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1994.tb13240.x     Document Type: Article

References (28)

1. Necrotizing enterocolitis
2. Breast milk and neonatal necrotising enterocolitis
3. Anti‐infective properties of breast milk
4. A randomised trial of oral immunoglobulin in low‐birth‐weight infants infected with rotavirus
5. Prevention of necrotizing enterocolitis in low‐birth‐weight infants by IgA‐IgG feeding
6. Treatment of infantile E. coli gastroenteritis with specific bovine anti‐E. coli milk immunoglobulins
7. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants
8. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum
9. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli
10. Oral administration of human serum immunoglobulin in immunodeficient patients with viral gastroenteritis: a pharmacokinetic and functional analysis
11. Manipulating the immune system with immune globulin
12. Secretory products of macrophages
13. The biology of cachectin/TNF—a primary mediator of the host response
14. Genomic structure, induction, and production of TNF–α
15. Interleukin‐6: an overview
16. The biology of interleukin‐6
17. Tumor necrosis factor and interleukin–1 in serum of children with severe infectious purpura
18. Prognostic values of tumor necrosis factor/cachectin, interleukin‐1, alpha‐interferon and gamma‐interferon in the serum of patients with septic shock
19. Role of platelet activating factor and tumor necrosis factor‐alpha in neonatal necrotizing entercocolitis
20. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet‐activating factor
21. Experimental model of ischemic bowel necrosis: the role of platelet‐activating factor and endotoxin
22. Platelet‐activating factor: an endogenous mediator for bowel necrosis in endotoxemia
23. Platelet activating factor‐induced ischemic bowel necrosis: the effect of PAF antagonists
24. Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use
25. Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits
26. Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3′:5′‐monophosphate levels, resulting in suppression of tumor necrosis factor alpha and interleukin‐1 production
27. Human intravenous immunoglobulin modulates monokine production in vitro
28. Cytokine induction in human mononuclear cells stimulated by IgG‐coated culture surfaces and by IgG for infusion